Skip to main content
logo
Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.720
+0.120 (4.62%)
At close: Nov 4, 2026, 4:00 PM EST
2.715
-0.006 (-0.20%)
After-hours: Nov 4, 2026, 7:59 PM EST

Editas Medicine Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Net Income
-18.23-24.98-5.62-25.12-53.24-76.09-45.4-62.14-67.61-61.95-18.87-45.02-40.29-49.04-60.74-55.73-53.45-50.52-41.44-39.08
Depreciation & Amortization
0.420.480.810.721.831.923.17-0.191.421.411.471.511.541.541.581.61.61.561.511.19
Loss (Gain) From Sale of Assets
0.11-0.03-2.193.720.010.14---1.58--1.58------
Asset Writedown & Restructuring Costs
-------1.791.79------------
Loss (Gain) From Sale of Investments
-0.14---0.06-0.26-0.58-0.87-1.33-1.88-1.72-2.1-1.25-0.78-0.69-0.72-----
Stock-Based Compensation
2.192.12.132.232.662.984.024.85.017.595.354.735.224.515.365.886.6211.437.6610.01
Other Operating Activities
0.931.18-0.522.41.212.642.19--0.42-1.6---0.23-0.28-0.180.230.330.42
Change in Accounts Receivable
-0.1312.58-7.05-7.54-0.0815.76-16.140.1209.94-7.77-0.14-2.044.9-5.030.590.66-1.11-0.020.08
Change in Accounts Payable
-0.061.73-0.56-3.561.26-0.03-7-1.257.42-1.46-2.592.36-0.7-0.562.690.421.48-0.231.84-1.16
Change in Unearned Revenue
-8.19--9.7--2-4.22-8.46---------2.18-5.52-11.33-5.67
Change in Other Net Operating Assets
-6.46-16.16-15.910.09-3.86.1119.55.48-1.01-3.692.272.34-1.651.9814.35-0.53.25-5.096.87-6.58
Operating Cash Flow
-29.57-23.06-36.39-30.84-50.21-47.8-50.76-52.59-57.06-49.87-22.24-35.46-38.71-35.77-42.27-48-37.85-49.23-34.58-40.79
Operating Cash Flow Growth (YoY)
--------------------

Investing Activities

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Capital Expenditures
-0.11-0.09-0.06-0.43--0.11-0.54-2.92-3.49-1.87-1.31-0.24-1.33-1.84-0.62-0.61-0.63-2.25-2.85-2.34
Sale of Property, Plant & Equipment
-0.160.12-0.15-----------0.02---
Investment in Securities
-29.69--40.0142.556.531.586.955.45-2.8764.15-102.5814.3225.11-26.989.84-3.3958.62-20-37.32
Investing Cash Flow
-29.80.060.0639.5742.6556.3930.9683.9851.95-4.7562.84-102.8212.9823.27-27.5389.23-456.37-22.84-39.66

Financing Activities

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Issuance of Common Stock
117.54-17.3317.177.411.440.27-0.320.190.51-117.53-0.620.080.370.221.062.5
Other Financing Activities
------2.8755.24-------------
Financing Cash Flow
117.54-17.3317.177.41-1.4455.51-0.320.190.51-117.53-0.620.080.370.221.062.5

Net Cash Flow

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Net Cash Flow
58.17-23-1925.9-0.157.1535.7131.39-4.79-54.4341.11-138.2891.8-12.5-69.1841.3-41.487.36-56.37-77.95

Free Cash Flow

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
-29.67-23.15-36.45-31.28-50.21-47.91-51.3-55.51-60.56-51.74-23.55-35.7-40.04-37.61-42.9-48.62-38.48-51.48-37.43-43.13
Free Cash Flow Growth (YoY)
--------------------
Free Cash Flow Margin
-249.57%-817.84%-147.31%-414.64%-1403.35%-1028.62%-167.63%-90998.36%-11804.29%-4558.85%-39.21%-669.00%-1387.05%-381.77%-656.32%-115757.14%-604.79%-760.23%-300.16%-695.97%
Free Cash Flow Per Share
-0.25-0.24-0.38-0.35-0.59-0.58-0.62-0.67-0.74-0.63-0.29-0.44-0.56-0.55-0.62-0.71-0.56-0.75-0.55-0.63
Levered Free Cash Flow
16.24-8.11-27.36-25.38-13.26-5.77-22.93-38.32-37.87-23.33-16.06-20.59-29.77-21.38-20.09-23.23-26.49-32.46-21.45-36.1
Unlevered Free Cash Flow
16.91-7.44-27.36-23.88-11.99-4.38-21.56-38.32-37.87-23.33-16.06-20.59-29.77-21.38-20.09-23.23-26.49-32.46-21.45-36.1

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash Interest Paid
5-2.13-2.13---------------
Change in Working Capital
-14.85-1.85-33.21-11.01-4.6217.62-12.14.346.414.8-8.094.56-4.46.3312.020.527.57-11.94-2.64-13.33
SEC Filings: 10-K · 10-Q